secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lucid Diagnostics Inc. (LUCD)
CIK:        0001799011
Form:       8-K
Filed at:   2025-09-10T23:59:59+00:00
Accession:  0001493152-25-012962
Event type: other_material
Sentiment:  negative
Materiality: 0.75
Item codes: 1.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Lucid Diagnostics prices $25M public offering of 25M shares at $1.00 per share
------------------------------------------------------------------------------

- Priced 25,000,000 shares of common stock at $1.00 per share; gross proceeds ~$25M before expenses.
- Underwriters granted 30-day option to purchase up to additional 3,750,000 shares at the same price.
- Net proceeds to be used for working capital and general corporate purposes; closing expected Sept 11, 2025.
- Canaccord Genuity and BTIG are joint bookrunners; Maxim Group is co-manager.
- Offering made under effective shelf registration statement S-3 (No. 333-268560).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1799011/000149315225012962/0001493152-25-012962-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1799011/000149315225012962/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-012962

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer